Plunkett Research Online: Merrimack Pharmaceuticals Inc

MERRIMACK PHARMACEUTICALS INC (MACK:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics paired with diagnostics for the treatment of cancer. The company has one marketed therapeutic oncology product and multiple targeted therapeutic oncology candidates in clini.....



Merrimack Pharmaceuticals Inc
Ticker: MACK
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 441-1000
Fax: 617 491-1386
Address: One Kendall Square
Suite B7201
Cambridge, MA 02139 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Richard PetersCEO/Director/President
Jean FranchiCFO/Chief Accounting Officer/Treasurer
See More
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics paired with diagnostics for the treatment of cancer. The company has one marketed therapeutic oncology product and multiple targeted therapeutic oncology candidates in clini.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
MM-121
MM-141
MM-310
MM-161
ATRi
BCL2/BCLXL
Trail
STIMULI
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: